… Allogeneic hematopoietic cell transplantation (HCT) is a … in patient and donor selection, stem
cell sources, supportive care, … and the pool of eligible patients have expanded significantly. …

… obstacles for the success of allogeneic hematopoietic stem cell transplantation (HSCT).
Progress in … Nonmyeloablative allogeneic stem cell transplantation represents a novel treatment …

… transplants it is possible to find a donor for most patients who today have an indication for
ASCT. The established state of the art of stem cell transplantation is … to bone marrow enhance …

… allogeneic hematopoietic cell transplantation (HCT) offers effective control and potential cure
of hematopoietic … suggest that greater than 60% of patients report good to excellent QOL in …

… cells and de novo production of naive T cells derived from transplanted stem cells and produced
in the recipient … the capacity for thymic-derived T cell production is greatly diminished in …

… patients had more severe GVHD. More recently, we reported that D+/R− recipients of non–T
cell–depleted stem cell transplants had higher TRM than did D−/R− control patients.45 …

… studies into the use of hematopoietic stem cell transplantation (HSCT) for therapy of cancer
and nonmalignant hematologic diseases have changed this treatment modality from one that …

… mortality in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Whether mortality
has decreased recently is unknown. The 497 adult allogeneic HSCT recipients admitted …

… Allogeneic hematopoietic cell transplantation (HCT) provides the best chance for cure for
many patients with malignant and nonmalignant hematologic disorders. Recent advances in …

… Allogeneic hematopoietic stem cell transplantation (HSCT) has become an integral part in
the treatment of hematological malignancies. As pretransplantation nutritional status affects …